CLINICAL EXPERIENCE WITH PIRFENIDONE IN FIVE PATIENTS WITH SCLERODERMA-RELATED INTERSTITIAL LUNG DISEASE

被引：6

作者：

Miura, Yukiko ^{[1
,2
]}

Saito, Takefumi ^{[1
]}

Fujita, Kazutaka ^{[1
]}

Tsunoda, Yoshiya ^{[1
]}

Tanaka, Toru ^{[1
]}

Takoi, Hiroyuki ^{[1
]}

Yatagai, Yohei ^{[1
]}

Rin, Shigen ^{[1
]}

Sekine, Akimasa ^{[1
]}

Hayashihara, Kenji ^{[1
]}

Nei, Takahito ^{[2
]}

Azuma, Arata ^{[2
]}

机构：

[1] Natl Hosp Org, Ibarakihigashi Hosp, Dept Resp Med, Tokyo, Japan

[2] Nippon Med Sch, Dept Pulm Med & Oncol, Grad Sch Med, Tokyo, Japan

来源：

SARCOIDOSIS VASCULITIS AND DIFFUSE LUNG DISEASES | 2014年 / 31卷 / 03期

关键词：

Antifibrotic agent; interstitial lung disease; pirfenidone; scleroderma; vital capacity;

D O I：

暂无

中图分类号：

R56 [呼吸系及胸部疾病];

学科分类号：

摘要：

Interstitial lung disease is the most common complication and cause of death among patients with scleroderma. Scleroderma-related interstitial lung disease has usually been treated with cyclophosphamide; however, its effect was evaluated to be modest and long-term administration of this drug is associated with adverse effects. Herein, we report our clinical experience of administering pirfenidone, which is an antifibrotic agent, in five patients with scleroderma-related interstitial lung disease. All patients demonstrated an increase in vital capacity.

引用

页码：235 / 238

页数：4

共 50 条

[31] Efficacy and safety of pirfenidone in systemic sclerosis-related interstitial lung disease-a randomised controlled trial [J].

Acharya, Nupoor ;

Sharma, Shefali Khanna ;

Mishra, Debashish ;

Dhooria, Sahajal ;

Dhir, Varun ;

Jain, Sanjay .

RHEUMATOLOGY INTERNATIONAL, 2020, 40 (05) :703-710

[32] Coagulation and Autoimmunity in Scleroderma Interstitial Lung Disease [J].

Ludwicka-Bradley, Anna ;

Silver, Richard M. ;

Bogatkevich, Galina S. .

SEMINARS IN ARTHRITIS AND RHEUMATISM, 2011, 41 (02) :212-222

[33] Longitudinal assessment of interstitial lung disease in single lung transplant recipients with scleroderma [J].

Hinze, Alicia M. ;

Lin, Cheng T. ;

Hussien, Amira F. ;

Perin, Jamie ;

Venado, Aida ;

Golden, Jeffrey A. ;

Boin, Francesco ;

Brown, Robert H. ;

Wise, Robert A. ;

Wigley, Fredrick M. .

RHEUMATOLOGY, 2020, 59 (04) :790-798

[34] The clinical and economic burden of systemic sclerosis related interstitial lung disease [J].

Morrisroe, Kathleen ;

Stevens, Wendy ;

Sahhar, Joanne ;

Ngian, Gene-Siew ;

Ferdowsi, Nava ;

Hansen, Dylan ;

Patel, Shreeya ;

Hill, Catherine L. ;

Roddy, Janet ;

Walker, Jennifer ;

Proudman, Susanna ;

Nikpour, Mandana .

RHEUMATOLOGY, 2020, 59 (08) :1878-1888

[35] Bronchoalveolar Lavage Fluid in Scleroderma Interstitial Lung Disease: Technical Aspects and Clinical Correlations: Review of the Literature [J].

Kowal-Bielecka, Otylia ;

Kowal, Krzysztof ;

Highland, Kristin B. ;

Silver, Richard M. .

SEMINARS IN ARTHRITIS AND RHEUMATISM, 2010, 40 (01) :73-88

[36] Clinical characteristics of patients with connective tissue disease–related interstitial lung disease: a retrospective analysis [J].

Seda Colak ;

Emre Tekgoz ;

Ezgi Cimen Gunes ;

Nesrin Ocal ;

Deniz Dogan ;

Canturk Tasci ;

Muhammet Cinar ;

Sedat Yilmaz .

Clinical Rheumatology, 2024, 43 :1693-1701

[37] Learnings from clinical trials in patients with connective tissue disease-associated interstitial lung disease [J].

Sevilla, Jean Paul Higuero ;

Memon, Areeka ;

Hinchcliff, Monique .

ARTHRITIS RESEARCH & THERAPY, 2023, 25 (01)

[38] Learnings from clinical trials in patients with connective tissue disease-associated interstitial lung disease [J].

Jean Paul Higuero Sevilla ;

Areeka Memon ;

Monique Hinchcliff .

Arthritis Research & Therapy, 25

[39] Patient perspectives on educational needs in scleroderma-interstitial lung disease [J].

Savvaides, Tina M. ;

Di Vitantonio, Thomas A. ;

Edgar, Armani ;

O'Beirne, Ronan ;

Krishnan, Jamuna K. ;

Kaner, Robert J. ;

Podolanczuk, Anna J. ;

Spiera, Robert ;

Gordon, Jessica ;

Safford, Monika M. ;

Lakin, Kimberly S. ;

Aronson, Kerri I. .

JOURNAL OF SCLERODERMA AND RELATED DISORDERS, 2025,

[40] Serum interleukin 23 and its associations with interstitial lung disease and clinical manifestations of scleroderma [J].

Gamal A. Hammad ;

Refaat M. Eltanawy ;

Rasha M. Fawzy ;

Tahany M. A. Gouda ;

Mona A. Eltohamy .

Egyptian Journal of Bronchology, 2018, 12 (1) :69-75

← 1 2 3 4 5 →